Because bone loss is accelerated by OCLs, the previous finding that therapeutic potentials of TMs on osteoporosis prompted us to investigate the correlation of TNFRSF11B expression and inhibitory activity of OPG on OCLs differentiation. The gene discussed is TNFRSF11B; the disease is osteoporosis.